On August 1, 2022 Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies for autoimmune diseases, enhance gene therapies and mitigate unwanted immune responses to biologics, reported that Company’s Management will participate in upcoming investor conferences in August (Press release, Selecta Biosciences, AUG 1, 2022, View Source [SID1234617205]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details on the conferences can be found below.
BTIG Biotechnology Conference 2022
Format: One-on-one investor meetings, attending virtually
Date: Monday, August 8 to Tuesday, August 9, 2022
Location: New York, NY
BTIG hosted events are intended for prospective and existing BTIG clients only. To schedule a meeting with the Company, please contact your BTIG representative.
Canaccord Genuity 42nd Annual Growth Conference
Format: Fireside chat and one-on-one investor meetings, attending in-person
Date: Wednesday, August 10, 2022
Time: 2:30 p.m. ET
Location: Boston, MA
Webcast: Click Here
An archived webcast of the Canaccord presentation will be accessible in the Investors & Media section of the company’s website at www.selectabio.com.